Scholar Rock’s Drug Shows Success in Late-Stage Study for Spinal Muscular Atrophy
Scholar Rock, a biotech company, announced on Monday that their new drug has shown promising results in a late-stage study for spinal muscular atrophy. The drug, called apitegromab, was tested in a year-long Phase...
Optimizing RSV Tools for a Successful New Season
Georgina Peacock shared a poignant memory of a night during her pediatric medical training when she admitted 20 babies struggling to breathe due to Respiratory Syncytial Virus (RSV). Since then, efforts have been relentless...
Remembering Sammy Basso: Progeria Advocate Who Passed Away at 28
Sammy Basso, a well-known advocate for progeria patients, passed away at the age of 28. Despite the challenges he faced due to his genetic disorder, Sammy was known for his ability to find humor...
Italian Acquisition and Medicare Advantage Market Growth in the Latest Pharmalittle Update
Good morning! This is Adam Feuerstein reporting from the Pharmalittle campus in Cambridge, Mass., filling in for our regular host Ed. Like Mr. Pharmalot, I start my day with a cup of coffee and...
Analyzing Hurricane Helene’s Impact on Healthcare and Vance’s Insights on Health Insurance
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Today’s item on bacterial outbreaks linked to hospital ice machines reminded me of The National’s song...
WuXi Considers Asset Sale Amidst BIOSECURE Act Uncertainty
Today, let's discuss the possibility of AI taking over cancer research, WuXi's decision to sell some of its operations due to the BIOSECURE Act, and more exciting news in the biotech world.AI in Cancer...
Navigating the Latest Changes in the Industry: Up and Down the Ladder
In the ever-evolving world of the pharmaceutical industry, it's crucial to stay updated on the latest changes and movements. Whether it's welcoming new faces, promoting internal talents, or filling key positions, sharing these updates...
Beware of Hospital Consolidation: Laura and John Arnold’s Warning
Hospital consolidation in the healthcare industry has led to increased prices for patients without improving the quality of care. Private equity firms and large health systems are acquiring hospitals and physician practices, resulting in...
Understanding the Impact of Hatch-Waxman and New-Patient Visit Times in Healthcare
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues...
Revised Title: Trump Abandons Plan to Lower Drug Prices by Tying Them to International...
Former President Trump has made a significant shift in his stance on a controversial drug pricing policy that aimed to tie drug prices in the U.S. to international rates. In 2020, Trump signed an...
Combatting Marburg Outbreak: Rwanda to Receive Experimental Vaccines and Therapeutics
Experimental vaccines and treatments to combat the Marburg virus outbreak in Rwanda are set to arrive this weekend. These will be used in clinical trials that are expected to start soon. The Marburg virus...
Improved Stool-Based Colon Cancer Test by Exact Sciences Receives FDA Approval
Exact Sciences recently received FDA approval for an improved version of their stool-based screening test for colon cancer. This new test, called Cologuard Plus, is designed to reduce the number of cancer-free patients who...